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o r i g i n a l a r t i c l e
Use of Medicare Claims to Rank Hospitals by Surgical Site Infection
Risk following Coronary Artery Bypass Graft Surgery
Susan S. Huang, MD, MPH;1,2 Hilary Placzek, MPH;1 James Livingston, MBA;1 Allen Ma, PhD;3 Fallon Onufrak, BS;1
Julie Lankiewicz, MPH;1 Ken Kleinman, ScD;1 Dale Bratzler, DO;3 Margaret A. Olsen, PhD, MPH;4
Rosie Lyles, MD, MHA;5 Yosef Khan, MD, MPH;6 Paula Wright, RN, BSN;7 Deborah S. Yokoe, MD, MPH;8
Victoria J. Fraser, MD;4 Robert A. Weinstein, MD;5 Kurt Stevenson, MD, MPH;6 David Hooper, MD;7
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objective. To evaluate whether longitudinal insurer claims data allow reliable identification of elevated hospital surgical site infection
(SSI) rates.
design. We conducted a retrospective cohort study of Medicare beneficiaries who underwent coronary artery bypass grafting (CABG)
in US hospitals performing at least 80 procedures in 2005. Hospitals were assigned to deciles by using case mix–adjusted probabilities of
having an SSI-related inpatient or outpatient claim code within 60 days of surgery. We then reviewed medical records of randomly selected
patients to assess whether chart-confirmed SSI risk was higher in hospitals in the worst deciles compared with the best deciles.
participants. Fee-for-service Medicare beneficiaries who underwent CABG in these hospitals in 2005.
results. We evaluated 114,673 patients who underwent CABG in 671 hospitals. In the best decile, 7.8% (958/12,307) of patients had
an SSI-related code, compared with 24.8% (2,747/11,068) in the worst decile ( ). Medical record review confirmed SSI in 40% (388/P ! .001
980) of those with SSI-related codes. In the best decile, the chart-confirmed annual SSI rate was 3.2%, compared with 9.4% in the worst
decile, with an adjusted odds ratio of SSI of 2.7 (confidence interval, 2.2–3.3; ) for CABG performed in a worst-decile hospitalP ! .001
compared with a best-decile hospital.
conclusions. Claims data can identify groups of hospitals with unusually high or low post-CABG SSI rates. Assessment of claims is
more reproducible and efficient than current surveillance methods. This example of secondary use of routinely recorded electronic health
information to assess quality of care can identify hospitals that may benefit from prevention programs.
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Surgical site infections (SSIs) are a leading adverse outcome
of medical care, with nearly 500,000 US cases annually.1-5 SSI
prevention is a major goal of the Joint Commission,6 the
Centers for Disease Control and Prevention (CDC),7 the Cen-
ters for Medicare and Medicaid Services (CMS) Surgical Care
Improvement Program,8 and the Institute for Healthcare Im-
provement.9 These initiatives depend on accurate assessment
of hospital infection rates. However, current SSI surveillance
performed by hospital-based infection preventionists uses a
labor-intensive process that is difficult to standardize. Most
SSIs have an incubation period that is longer than postop-
erative stays, which further confounds surveillance by hos-
pital-based detection programs.10-16 In addition, current re-
porting standards fail to adjust for hospital case mix and
ignore well-established SSI risk factors, such as age and di-
abetes.17-20 This can unfairly disadvantage hospitals serving
sicker patients. Currently reported SSI rates are thus a poor
foundation for evaluating hospital performance.
Claims data have several potential advantages for simpli-
fying and standardizing SSI detection: (1) uniform identifi-
cation of subsequent procedures suggesting SSI (eg, reoper-
ation, abscess debridement); (2) detection of care in all
settings, including outpatient facilities and other hospitals;
(3) existence of validated case mix adjustment methods;18-22
and (4) ready availability and ease of analysis.
We previously showed that claims data can successfully




34.00 Incision of chest wall and pleura
34.01 Incision of chest wall
34.02 Exploratory thoracotomy
34.10 Incision of mediastinum
86.01 Aspiration of skin and subcutaneous tissue (abscess, hematoma, seroma)
86.04 Other incision with drainage of skin and subcutaneous tissue
86.09 Other incision of skin and subcutaneous tissue
86.22 Excisional debridement of wound, infection, or burn
86.28 Nonexcisional debridement of wound, infection, or burn
91.71 Operative wound: gram stain
91.72 Operative wound: culture
91.73 Operative wound: culture and sensitivity
513.1 Abscess of mediastinum
519.2 Mediastinitis
682.2 Cellulitis of trunk
682.3 Cellulitis of upper arm/forearm
682.8 Cellulitis, other specified sites
686.8 Other specified local infections of skin and soft tissue
686.9 Unspecified local infection of skin/soft tissue
730.00 Acute osteomyelitis, site unspecified
730.08 Acute osteomyelitis, other specified site
730.09 Acute osteomyelitis, multiple sites
730.20 Osteomyelitis, site unspecified
730.28 Osteomyelitis, other specified site
730.29 Osteomyelitis, multiple sites
730.30 Periostitis, site unspecified
730.38 Periostitis, other specified site
730.39 Periostitis, multiple sites
730.80 Other infections involving bone in diseases classified elsewhere, site unspecified
730.88 Other infections involving bone in diseases classified elsewhere, other specified site
730.89 Other infections involving bone in diseases classified elsewhere, multiple sites
730.90 Unspecified infection of bone, site unspecified
730.98 Unspecified infection of bone, other specified site
730.99 Unspecified infection of bone, multiple sites
785.52 Septic shock
790.7 Bacteremia
875.0 Open wound into thoracic cavity without complication
879.8 Open wounds without mention of complications
879.9 Open wounds, unspecified, complicated
891.0 Open wound of leg without mention of complication
891.1 Open wound of leg with complication
996.60 Infection and inflammatory reaction due to unspecified device, implant
996.61 Infection and inflammatory reaction due to cardiac device, implant
996.62 Infection and inflammatory reaction due to vascular device, implant
996.71 Other complications due to heart valve prosthesis
998.31 Disruption of internal operation wound
998.32 Disruption of external operation wound
998.51 Infected postoperative seroma
998.83 Nonhealing surgical wound
998.9 Unspecified complication of procedure, not otherwise specified
CPT
10060 Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess,
cyst, furuncle, or paronychia); simple or single
10061 Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess,
cyst, furuncle, or paronychia); complicated or multiple
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table 1 (Continued)
Code Code text
10140 Incision and drainage of hematoma, seroma, or fluid collection
10160 Puncture aspiration of abscess, hematoma, bulla, or cyst
10180 Incision and drainage, complex, postoperative wound infection
11010 Debridement, including removal of foreign material associated with open fractures and/or dislocation; skin and
subcutaneous tissues
11040 Debridement, skin, partial thickness
11041 Debridement, skin, full thickness
11042 Debridement, skin and subcutaneous tissue
11043 Debridement, skin, subcutaneous tissue, and muscle
11044 Debridement, skin, subcutaneous tissue, muscle, and bone
12020 Treatment of superficial wound dehiscence; simple closure
12021 Treatment of superficial wound dehiscence; with packing
13160 Secondary closure of surgical wound or dehiscence, extensive or complicated
20000 Incision of soft tissue abscess, superficial
20005 Incision of soft tissue abscess, deep
39000 Mediastinotomy with exploration, drainage, removal of foreign body or biopsy; cervical approach
39010 Mediastinotomy with exploration, drainage, removal of foreign body or biopsy; transthoracic approach
rank a small number of Massachusetts hospitals by coronary
artery bypass grafting (CABG) SSI rates23 and demonstrated
that this methodology can be implemented by payers.24 We
now evaluate the ability of Medicare claims data to rank US
hospitals by their SSI rates after CABG. Applicability of claims
data for this purpose would be an important example of the
secondary use of routinely collected health information to
improve the quality of care and patient safety.
methods
This was a 3-phase study. First, we used a claims-based al-
gorithm based on prior work23,24 and piloted it in 5 hospitals
to assess the relative sensitivity of routine surveillance and
the algorithm. Second, on the basis of these results, we mod-
ified the algorithm and applied it to 2005 Medicare claims,
ranking hospitals into deciles based on case mix–adjusted
claims-based SSI rates. Third, we performed chart reviews of
a sample of cases in the best- and worst-performing deciles
to assess claims-based performance characteristics.
Participating Organizations and Roles
The study was performed by the CDC Prevention Epicen-
ters,25 led by the epicenter based at Harvard’s Department of
Population Medicine, in collaboration with the Oklahoma
Foundation for Medical Quality (OFMQ) acting in its ca-
pacity as a national hospital quality resource center for Med-
icare’s Quality Improvement Organization Program. With the
exception of the chart reviews for the national validation,
OFMQ maintained possession of all information containing
hospital identifiers or individual-level data, using computer
programs developed jointly with investigators.
This study was conducted through an interagency agree-
ment between CMS and CDC. Institutional Review Board
approval was received at all participating CDC Prevention
Epicenter sites.
Phase 1: Comparing a Claims-Based Algorithm for CABG
SSI Detection with Routine Surveillance
We applied a claims-based algorithm based on prior work23,24
to Medicare claims from 5 CDC Prevention Epicenter hos-
pitals. CMS claims were used to identify Medicare patients
who had CABG procedures in 2005 (ICD-9-CM 36.10–36.17,
36.19, 36.2). Members of Medicare Advantage plans were
excluded because claims are not available; reimbursement in
these plans is not based on submitted claims. Repeat CABG
procedures within 60 days were excluded.
SSIs were suspected if the algorithm identified patients with
any of an extensive set of diagnostic (ICD-9) or procedure
(ICD-9, CPT) codes occurring within 60 days after CABG.23,24
A 60-day window was selected to maximize the number of
CABG procedures evaluated in the available data set. Al-
though hospitals often track SSIs for 1 year after CABG due
to the presence of sternal wires, the 60-day window accounts
for the majority of SSIs. For most surgeries, CDC SSI criteria
require symptoms to begin within 30 days after surgery. We
used 60 days to account for the fact that patients may seek
care several weeks after the onset of symptoms.
CDC SSI criteria26 were applied to the medical records of
these patients and any additional Medicare patients with SSI
identified through routine surveillance based on records from
hospital infection prevention programs. On the basis of these
results, the algorithm was refined by eliminating codes con-
sistently identifying other postsurgical events while failing to
identify SSIs.
The performance of the revised claims-based algorithm was
compared with routine infection control surveillance by com-
paring (x2) the fraction of chart review–confirmed cases iden-
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figure 1. Unadjusted hospital-specific coronary artery bypass grafting (CABG) rates of occurrence of surgical site infection (SSI) codes
by rank order for all 671 US hospitals performing at least 80 CABGs in Medicare patients. Bar markers indicate median values within a
decile.
tified by each method divided by the total chart-confirmed
cases by either method.
Phase 2: Applying the Algorithm to the National Medicare
Population to Rank US Hospitals
The algorithm was applied to a 2005 Medicare data set in-
cluding all non-managed-care Medicare patients who un-
derwent CABG procedures in US hospitals performing at least
80 annual CABG procedures in this population. The restric-
tion to higher-volume institutions was made to focus on hos-
pitals whose rates would not be unduly influenced by the
detection or failure to detect a small number of infections.
Hospital-specific unadjusted claims-based SSI rates were
calculated.
We fit a logistic regression predicting claims-based SSI per
CABG. To adjust for case mix, the model included age, sex,
open or minimally invasive surgery, and the Romano score
(an adaptation of the Charlson index, an ICD-9-based co-
morbidity score including 19 conditions evaluated in the year
before surgery). The Romano score has been shown to per-
form best in adjusting for comorbidity in claims data and
predicts mortality in Medicare patients.22 Clustering within
hospital was accounted for by including a random intercept
and using generalized linear mixed models (GLMMs).27 Hos-
pital-specific SSI probabilities, including the predicted ran-
dom effects, were adjusted for case mix and Medicare CABG
volume. Hospitals were ranked by deciles of these SSI prob-
abilities. All analyses were performed in SAS, version 9.1.
Phase 3: Validation of Ranking in Extreme Deciles
We randomly selected for review 750 patients identified by
the claims-based algorithm as having a code suggestive of SSI
whose CABG was performed in a hospital in the best and
worst deciles for adjusted SSI risk (1,500 patients total).
Charts were requested from hospitals and outpatient clinics
where an SSI claim code had been filed.
Charts with claims occurring on the day of surgery and
those related to home health visits were excluded. Charts from
all other visit types were requested, and all received charts
were reviewed for post-CABG SSI.
We compared patient characteristics among those for
whom charts were received or not received using x2 tests.
The x2 tests were also used to compare the proportion of
patients with any received record who had a confirmed SSI
among best- and worst-decile hospitals. SSIs were described
by location (sternal/donor site) and CDC-defined depth (su-
perficial incisional/deep incisional/organ space).
Finally, we performed a case-control study to assess
whether having a CABG performed in a worst- versus best-
decile hospital was associated with higher risk of confirmed
SSI. Cases were defined as patients with codes suggestive of
SSIs and chart-confirmed SSIs. Controls were defined as the
collection of 3 groups. The first group included patients with
codes suggestive of SSI whose medical records revealed no
SSI. The second group included patients selected for chart
review whose medical records were not returned. This group
assumes that none of the charts that failed to be returned
would have confirmed SSI, a conservative assumption. The
third group was a random sample of same-decile patients
with no codes suggestive of SSI. This group was selected in
proportion to the fraction of patients with an SSI code who
were chosen for chart review. This group was included among
the controls under the assumption that none of them had an
SSI. The data analysis was based on a GLMM that was fit to
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figure 2. Plot of hospitals based on hospital-specific percents of
Medicare patients who had surgical site infection (SSI) codes fol-
lowing coronary artery bypass grafting (CABG) procedures. Raw
percents are compared with percents adjusted for age, sex, and co-
morbidities. Each hospital is depicted as a circle whose size reflects
the number of patients. Decile markers (lines) are provided for best
and worst deciles for raw and adjusted SSI percents. Hospitals ranked
in B (55 hospitals) and E (53 hospitals) have raw and adjusted SSI
percents located in the same decile (best or worst). Hospitals ranked
in C (12 hospitals) have an unadjusted percent that places them in
the worst decile, but their adjusted percentile places them out of
the worst decile. Hospitals ranked in A (12 hospitals) have an un-
adjusted SSI percent that places them above the worst decile, but
their adjusted percent places them to the worst decile. Likewise,
hospitals in D (15 hospitals) would be included in the best decile
with unadjusted but not adjusted percent, and F (15 hospitals) in-
cludes hospitals with adjusted but not unadjusted percents in the
best decile. One hospital with unadjusted 64% SSI was excluded
from the plot but would have appeared in B.
estimate the odds ratio of being a case in the best- versus
worst-decile hospital, adjusted for age, sex, minimally invasive
CABG, and comorbidity score and accounting for clustering
by hospital.
results
Phase 1: Comparing the Claims-Based Algorithm with
Routine Hospital Surveillance
The 5 hospitals performed 1,102 CABGs among Medicare
beneficiaries in 2005 (average, 220; range, 87–340). On the
basis of the final algorithm, 12% ( ) of patients (hos-Np 128
pital range, 9%–16%) had an SSI code that resulted in chart
review. Among patients with SSI codes, chart review con-
firmed SSI in 36% ( ; hospital range, 15%–62%). TheNp 48
claims-based diagnostic and procedure codes in the final al-
gorithm are found in Table 1.
Using chart-confirmed SSI of patients identified through
claims, routine surveillance, or both, we found that the sen-
sitivity of claims-based surveillance was significantly higher
than that of routine surveillance ( ). The claims-basedP ! .001
algorithm identified all but 2 SSIs found by hospital infection
prevention programs, resulting in 96% (48/50) sensitivity
(range, 86%–100%) for SSI detection. In contrast, hospital
routine surveillance missed 26 patients with confirmed SSI,
resulting in a 48% (24/50) sensitivity for SSI (range,
14%–100%). The majority of cases missed by infection pre-
vention programs involved SSIs that met CDC criteria but
did not have a microbiology culture.
Phase 2: Claims-Based Ranking of US Hospitals by SSI
Rates
There were 114,586 CABG procedures among fee-for-service
Medicare beneficiaries during 2005 at 671 hospitals that per-
formed at least 80 CABG procedures (median, 132; range,
80–822). The median proportion of patients with diabetes
across hospitals was 44%, with 9% end-stage renal disease
and 63% vascular disease. The median Romano score was 5,
with only 6% of patients with a score of 0.
Across hospitals, the unadjusted percent of patients with
codes suggestive of SSI ranged from 4.2% to 64.5% (Figure
1). The percent of patients with codes suggestive of SSI across
all surgeries performed in the best-decile hospitals (7.8%
[963/12,313]) was significantly lower than in the worst-decile
hospitals (25.3% [2,824/11,146]; ). UnadjustedP ! .001
hospital-specific percent of patients with codes suggestive of
SSI are plotted against adjusted percents in Figure 2.
Adjustment resulted in 8% (54/671) of hospitals moving
into or out of the best and worst deciles. In the worst decile,
55 (82%) hospitals remained there after adjustment; for the
best decile, this was the case for 53 (79%) hospitals. Char-
acteristics of patients with and without SSI codes are provided
in Table 2 for hospitals in the best and worst deciles, after
adjustment.
Phase 3: Chart Review Validation
Of the 1,500 patients randomly selected for chart review, 114
patients were excluded because their codes suggestive of SSI
were limited to home health claims ( ) or claims onNp 83
the day of surgery ( ). The remaining 716 patientsNp 31
from best-decile hospitals and 670 patients from worst-decile
hospitals had medical records requested from all visits with
a code suggestive of SSI. We requested 2,717 records, rep-
resenting 4,181 claims with SSI codes. We received at least 1
requested chart for 71% of patients.
Inpatient charts were most consistently returned (97%),
followed by outpatient visits listed by clinic name and address
(90%), nursing homes (70%), and then outpatient visits listed
by the physician’s name and address (35%). The low return
rate among physician office claims was because physicians
often had several offices but listed only 1 address for claims.
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table 2. Characteristics of Patients in Hospitals with the Highest and Lowest Percentages of Patients with
a Surgical Site Infection (SSI) Diagnosis or Procedure Code









No. of casesa 958 11,349 2,747 8,321
Age, years
Overall mean (SD) 74.9 (5.8) 74.4 (5.8) 75.3 (6.1) 74.8 (6.1)
65–74, % 54 56 49 53
75–84, % 41 41 45 42
85, % 5 4 6 5
Male, % 59 66 60 68
Minimally invasive, % 43 37 35 27
Romano score
Overall mean (SD) 5.1 (2.9) 3.5 (2.6) 5.2 (2.9) 3.9 (2.8)
Low (0), % 6 11 6 10
Medium (1–4), % 45 57 43 54
High (5), % 49 32 51 36
a Note that the total number of patients in the best and the worst decile are not the same because deciles
are based on hospital-specific SSI rates from claims data. Numbers reflect the combined coronary artery
bypass grafting surgical volume of hospitals in the best and worst decile by SSI rates.
Thus, many requests were returned because no patient with
the provided name was seen at that clinic.
Characteristics of patients with reviewed records are pro-
vided in Table 2. Descriptors were similar in all aspects among
those with and without records available for review.
Once a claim identified a potential SSI, the decile (best vs
worst) had little impact on the probability that SSI would be
confirmed by chart review: 41% (221/538) of patients with
a code suggestive of SSI were confirmed in the best decile
and 38% (167/442) in the worst decile ( ; Table 3).Pp .3
Thus, while best-decile hospitals had fewer patients with a
code suggestive of SSI than did worst-decile hospitals, once
identified, the confirmation fraction was similar.
The proportions of chart-confirmed SSIs between best and
worst deciles were statistically similar across inpatient claims
(29% [158/538] vs 26% [114/442]; ) and outpatientPp .6
claims (21% [113/538] vs 21% [95/442]; ) and whetherPp .3
SSIs were superficial incisional (19% [104/538] vs 19% [83/
442]; ), deep incisional (12% [64/538] vs 11% [48/Pp .9
442]; ), or organ space (10% [53/538] vs 8% [36/Pp 1.0
442]; ). Confirmation of sternal infections was alsoPp .6
statistically similar (27% [114/442] vs 22% [96/442]; Pp
), but best-decile hospitals had significantly fewer confirmed.2
donor site infections compared with worst-decile hospitals
(16% [85/538] vs 19% [83/442]; ).Pp .03
In the case-control analysis, 3.2% of subjects in best-decile
hospitals and 9.4% of patients undergoing CABG in worst-
decile hospitals experienced chart-confirmed SSI. When we
adjusted for age, sex, comorbidities, and clustering within
hospital, patients having a CABG performed in a worst-decile
hospital compared with a best-decile hospital had a 2.7-fold
higher odds of confirmed post-CABG SSI (Table 4). Female
sex and increasing comorbidity score were also associated
with SSI. Older age was associated with a lower risk of SSI.
discussion
Our goals were to compare the performance of a claims-based
algorithm using routinely collected diagnosis and procedure
codes with that of typical hospital surveillance and to deter-
mine whether these codes were a sufficient surrogate measure
of SSI to identify hospitals likely to have high (or low) rates
of SSI after CABG. This is thus an example of the secondary
use of routinely electronic health data to improve healthcare
quality. The intended use of this approach is to perform rou-
tine periodic assessment of very large claims data sets to
identify institutions that merit additional evaluation. Medi-
care claims are currently the largest such data set, but others
for which this approach may be considered include large
insurers and multipayer databases that are being developed.
Medicare claims identified twice as many patients with
chart-confirmed post-CABG SSI than did routine hospital-
based surveillance by infection control and prevention pro-
grams in 5 academic health centers. Infections that occurred
after discharge and those lacking microbiologic cultures con-
tributed to the extra yield. Nationally, Medicare claims also
identified a group of hospitals with high aggregate confirmed
post-CABG SSI rates.
Since the proportion of patients with a claim suggestive of
SSI was proportional to the rate of chart-confirmed SSI, rou-
tine evaluation of diagnosis and procedure codes may be a
useful screening method for CMS and other insurers to iden-
tify hospitals that merit additional evaluation based on au-
tomated analysis of centralized insurer data. Our findings do
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table 3. Characteristics of Patients with Medical Records Re-
viewed to Confirm Surgical Site Infections (SSIs)
Best decile Worst decile
N 538 442
Age, years
Overall mean (SD) 74.3 (5.7) 74.5 (6.0)
65–74, % 54 53
75–84, % 41 42
85, % 5 5
Male, % 58 60
Minimally invasive, % 43 34
Romano score
Overall mean (SD) 4.7 (2.8) 4.8 (3.0)
Low (0), % 6 7
Medium (1–4), % 47 41
High (5), % 48 52
Chart-confirmed SSI, % 41 38
Inpatient 29 26
Outpatient 21 21
Nursing home 1 1
Sternal SSI, % 27 22
Superficial 12 10
Deep 5 4
Organ space 10 8
Donor SSI, % 16 19
Superficial 9 11
Deep 7 8
Organ space 0 0
table 4. Predictors of Confirmed Surgical Site Infection
(SSI) after Coronary Artery Bypass Grafting (CABG)
Odds ratio
(confidence interval) P value
CABG performed in worst-
vs best-decile hospital 2.7 (2.2, 3.3) !.001
Age, years .001
65–74 1.0
75–84 0.7 (0.5, 0.8)
85 0.6 (0.4, 1.0)
Female 1.7 (1.4, 2.1) !.001
Open vs minimally invasive 1.0 (0.8, 1.2) .8
Romano score !.001
Low (0) 1.0
Medium (1–4) 1.4 (0.9, 2.2)
High (5) 2.5 (1.6, 4.0)
not imply that every hospital with a high proportion of SSI
codes has a high rate of confirmed SSI. Targeted evaluation
of hospitals with a high proportion of codes would be needed
to confirm actual rates of SSI.28 It will also be important to
determine whether additional case mix adjustment is also
warranted, using measures not available in claims data, such
as ventricular function and functional status.
Use of national data sets to identify outlier hospitals would
allow quality improvement organizations and others to direct
evaluation and quality improvement activities toward hos-
pitals in greatest need of evaluation and assistance. This use
is highly consistent with the current emphasis on meaningful
use of electronic health data by CMS and the Office of the
National Coordinator of Health Information Technology,
namely, “capturing health information in a coded format,
using that information to track key clinical conditions, com-
municating that information for care coordination purposes,
and initiating the reporting of clinical quality measures and
public health information.”29
This approach can also be used by insurers or states to
assess hospital post-CABG SSI rates as previously shown;19,20
such methods would be especially powerful if they combined
data across payers. Claims-based evaluations could identify
best-practice hospitals that have consistently low SSI rates,
perhaps allowing identification of practices that account for
low SSI rates.
The use of routinely collected electronic health information
has several advantages over traditional methods, including
improved adjustment for case mix, conservation of scarce
infection preventionist resources, and minimizing variability
in surveillance methods. Currently, SSI surveillance is not
standardized and often misses postdischarge events and SSIs
lacking culture data.
While the use of claims has several advantages, this study
has important limitations. First, we validated only the ability
of this algorithm to distinguish hospitals in the extreme (best
or worst) deciles. We also chose not to review home health
or day-of-surgery codes, although we note that a higher pro-
portion of these codes were found in the worst-decile hos-
pitals. Had these confirmed SSIs, it would have only strength-
ened our findings. Second, this approach is not helpful for
evaluating hospitals with low Medicare procedure volumes.
We do not know whether our threshold of 80 procedures per
year is optimal. It will be worthwhile to assess the applicability
of this approach to hospitals that perform fewer procedures.
Third, claims data depend on hospital coding practices.
For this reason, we selected an extensive set of codes to pre-
vent “gaming the system” by choosing alternative codes that
described the same disease process. However, to the extent
that the SSI codes become known, it will be possible for
clinicians or institutions to avoid their use. Fourth, while our
case mix adjustment method included more factors than is
standard for SSI reporting, it omitted important risk factors,
such as obesity. As such information becomes more widely
available in electronic medical records, it should be incor-
porated into standard case mix adjustment. Until then, it will
be necessary to take such factors into account during the
evaluation of outlier hospitals. Finally, our results are limited
by partial return of requested charts for medical record val-
idation of SSIs. Since we assumed that all those without re-
turned charts had no SSIs, we underestimated the ability of
claims to detect post-CABG SSIs.
We have no information about important aspects of this
ranking system, especially whether hospitals’ rankings persist
782 infection control and hospital epidemiology august 2011, vol. 32, no. 8
year to year and whether this approach is applicable to other
surgeries.
In conclusion, routinely collected electronic claims can
identify hospitals with unusually high post-CABG SSI risks.
This method is more sensitive and efficient than current hos-
pital-based surveillance methods. It is an example of the
meaningful use of electronic health data to support national
improvements in healthcare quality and patient safety.
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